Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing

Inclusion Criteria

• Any participant who is receiving study treatment and deriving significant clinical benefit or is in the safety and/or survival follow-up period in a Pfizer-sponsored Avelumab Parent Study.
• Participants must agree to follow the reproductive criteria.
• Participants must be willing and able to comply with all scheduled visits, treatment plan, and other study procedures.

Exclusion Criteria

• Female participants who are pregnant or breastfeeding.
• Any medical reason that, in the opinion of the Investigator or Sponsor, precludes the participant from inclusion in the study.